Evaluation of Galactomannan from Gleditsia Sinensis Lam. as Sustained Release Material in Colonic Drug Delivery

Abstract:

The galactomannan from endosperm of G. sinensis seeds was used as sustained release material in the matrix tablets prepared at different concentration of 5, 10 and 15 % corresponding to formulations of G5, G10 and G15, for the release of theophylline. The drug release behaviors of the systems were investigated, including the swelling and morphological studies and texture analysis. The dissolution tests were conducted in 0.1 M hydrochloric acid and pH 6.8 phosphate buffered saline. The results of release studies demonstrated that G10 with 10 % galactomannan concentration showed a better control of the drug release profiles. The percents of cumulative drug released in 24 h were 98.8, 90.2 and 83.4 % for G5, G10 and G15, respectively. All the systems exhibited the typical morphological behavior of a swellable matrix. Results of texture analysis on the swollen tablets confirmed that diffusion drug release mechanism played the major role in G10 and G15 systems while the drug delivery kinetic towards an erosion/relaxation mechanism for G5 matrix tablets.

• Periodical: Advanced Materials Research (Volumes 146-147)
• Pages: 589-598
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.146-147.589
• Online since: October 2010
• Authors: Hong Lei Jian, Li Wei Zhu, Wei Ming Zhang, Xiang Qi, Jian Xin Jiang
• Keywords: Drug Release, Galactomannan, Gleditsia sinensis, Matrix Tablet, Theophylline

References

[1] M. Ashford and J.T. Fell: Journal of Drug Targeting, 2(3), 241-257 (1994).

[2] J.H. Cummings, D.A.T. Soutgate, W.J. Branch, H.S. Wiggins, H. Houston, D.J.A. Jenkins, T. Jivraj and M.J. Hill: British Journal of Nutrition, 41, 466-485 (1979).

[3] A.W. Basit: Drugs, 14(65), 1991-2007 (2005).

[4] Y.V. Rama-Prasad, Y.S.R. Krishnaiah and S. Satyanarayana: Indian Drugs, 33, 1-10 (1996).

[5] T.F. Vandamme, A. Lenourry, C. Charrueau and J. Chaumeil: Carbohydrate Polymers, 3(48), 219-231 (2002).

[6] M.K. Chourasia and S.K. Jain: Drug Delivery, 2(11), 129-148 (2004).

[7] V.R. Sinha and K. Rachna: International Journal of Pharmaceutics, 224, 19-38 (2001).

[8] J.P.F. Bai, L.L. Chang and J.H. Guo: Critical Review in Therapeutic Drug Carrier Systems, 12(4), 339-371 (1995).

[9] P. Watts and L. Illum: Drug Development and Industrial Pharmacy, 23(9), 893-913 (1997).

[10] X. Li, M. J. Fan, L.B. Feng, X.Q. Shan and Y.H. Feng: Journal of Integrative Plant Biology, 3, 302-304 (1980).

[11] A.M. Goldstein, E.N. Alter and J.K. Seaman, in: Industrial gums, Polysaccharides and their derivatives, edited by R.L. Whistler, Academic Press, New York (1973).

[12] L. Hovgaard and H. Brondsted: Critical Review in Therapeutic Drug Carrier Systems, 13, 185-223 (1996).

DOI: 10.1615/critrevtherdrugcarriersyst.v13.i3-4.10

[13] S. Kiil and K. Dam-Johansen: Journal of Control Release, 90, 1-21 (2003).

[14] K.O.R. Lehamann and K.D. Dreher: Proceeding International Symposium Controlled Release Bioactive Material, 18, 331-332 (1991).

[15] N. Nakajima and Y. Matsuura: Bioscience Biotechnology and Biochemistry, 10(61), 1739-1742 (1997).

[16] J.X. Jiang, W.M. Zhang, L.W. Zhu, J.S. Xu, S.D. Zhao and M.T. Ma: Chinese Wild Plant Resources, 22(5), 34-36 (2003).

[17] O. Bayraktar, Ö. Malay, Y. Özgarip and A. Batıgün: European Journal of Pharmaceutics and Biopharmaceutics, 60, 373-381 (2005).

[18] F. Alvarez-Manceñido, M. Landin and R. Martínez-Pacheco: European Journal of Pharmaceutics, 69, 573-581 (2008).

DOI: 10.1016/j.ejpb.2008.01.004

[19] Y.V. Rama-Prasad, Y.S.R. Krishnaiah and S. Satyanarayana: Journal of Controlled Release, 51, 281-287 (1998).

[20] M.M. Talukdar and J. Plaizier-Vercammen: Drug Development and Industrial Pharmacy, 19(11), 1037-1046 (1993).

DOI: 10.3109/03639049309062999

[21] N. Billa and K.H. Yuen: AAPS Pharmaceutical Science and Technology, 1(4), 1-8 (2000).

[22] C.W. Vendruscolo, I.F. Andreazza, J.L.M.S. Ganter, C. Ferrero and T.M. B: International Journal of Pharmaceutics, 296, 1-11 (2005).

[23] P.I. Lee and N.A. Peppas: Journal of Controlled Release, 6, 207-215 (1987).

[24] P.L. Ritger and N.A. Peppas: Journal of Controlled Release, 5(1), 23-36 (1987).

[25] N.A. Peppas and J.J. Sahlin: International Journal of Pharmaceutics, 57, 169-172 (1989).

[26] S.K. Baveja, K.V. Ranga-Rao, J. Arora, N.K. Mathur and V.K. Vinayah: Indian Journal of Chemistry, 30, 133-137 (1991).

[27] O.A. Cavalcanti, L.M. Cabral, B.C. Baudner, E. Murtas, F.M. Riccieri and F. Alhaique: Acta Technologiae et Legis Medicamenti, 9, 149-159 (1998).

[28] M. Üner and T. Altınkurt. Farmaco, 59, 567-573 (2004).

[29] D.L. Munday and P.J. Cox: International Journal of Pharmaceutics, 203, 179-192 (2000).

[30] K. Ueberreiter, In: Diffusion in Polymers, edited by J. Crank and G.S. Park, Academic Press, London (1967).

[31] S. Conti, L. Maggi, L. Segale, E. Ochoa-Machiste, U. Conte, P. Grenier and G. Vergnault: International Journal of Pharmaceutics, 333, 136-142 (2007).

DOI: 10.1016/j.ijpharm.2006.11.059